Related Experiment Video
Updated: May 29, 2026

Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
African American living-kidney donors should be screened for APOL1 risk alleles
David M Cohen1, Anuja Mittalhenkle, David L Scott
1Division of Nephrology and Hypertension, Department of Medicine, Oregon Health & Science University, Portland, OR 97239, USA. cohend@ohsu.edu
Insights
African Americans face higher end-stage kidney disease (ESKD) rates and longer transplant waits. Screening for APOL1 risk alleles in living kidney donors could improve outcomes for this population.
Area of Science:
- Nephrology
- Genetics
- Transplantation
Background:
- African Americans experience disproportionately higher rates of end-stage kidney disease (ESKD) compared to European Americans.
- This disparity leads to overrepresentation on kidney transplant waiting lists and extended wait times for African American patients.
- Living donor transplantation is often recommended to mitigate these challenges.
Purpose of the Study:
- To propose a screening strategy for APOL1 risk alleles in potential living kidney donors.
- To address the genetic factors contributing to ESKD risk in African Americans.
- To optimize kidney transplantation for African American recipients and their donors.
Main Methods:
- Reviewing the genetic link between APOL1 risk alleles and ESKD.
- Analyzing the prevalence of APOL1 risk alleles in African Americans.
- Developing a proposed screening protocol for living kidney donors.
Main Results:
- The APOL1 gene has been implicated in ESKD risk, particularly among African Americans.
- Possessing two APOL1 risk alleles significantly doubles the relative risk for ESKD.
- These risk alleles are common within the African American population.
Conclusions:
- A targeted screening approach for APOL1 risk alleles is warranted.
- Screening African American living kidney donors and living-related donors for African American recipients is proposed.
- This strategy aims to improve kidney transplantation equity and outcomes.
Abstract:
The adjusted rate of end-stage kidney disease (ESKD) among African Americans is markedly increased relative to European Americans. African Americans are overrepresented on the kidney transplantation waiting list and experience longer wait times. In aggregate, these pressures drive recommendations for living donor transplantation. Genovese et al. recently implicated the APOL1 gene in ESKD risk among African Americans (Genovese et al. Science 2010; 329: 841). The presence of two APOL1 risk alleles doubles the relative risk for ESKD; moreover, the alleles are prevalent among African Americans. We propose a strategy for screening for the presence of APOL1 risk alleles among African American living kidney donors and for living-related donors for African American recipients.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant III: Nursing Management
Chronic Kidney Disease I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
